Caribou Biosciences
CRBU
129 hedge funds and large institutions have $103M invested in Caribou Biosciences in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 44 increasing their positions, 32 reducing their positions, and 28 closing their positions.
107% more call options, than puts
Call options by funds: $344K | Put options by funds: $166K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
38% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 32
18% more capital invested
Capital invested by funds: $87.6M → $103M (+$15.5M)
0.9% less ownership
Funds ownership: 58.86% → 57.96% (-0.9%)
8% less funds holding
Funds holding: 140 → 129 (-11)
36% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.54M |
| 2 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$1.45M |
| 3 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$1.42M |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$1.39M |
| 5 |
Morgan Stanley
New York
|
+$1.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.82M |
| 2 |
RCMU
Rokos Capital Management (UK)
London,
United Kingdom
|
-$1.37M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.17M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.03M |
| 5 |
Goldman Sachs
New York
|
-$999K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
151
Simplex Trading
Chicago,
Illinois
| – | -$17.6K | -8,613 | Closed |
|
152
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$3.88K | -2,444 | Closed |
|
|
NFSG
153
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$3.28K | -2,000 | Closed |
|
154
Optiver Holding
Amsterdam,
Netherlands
| – | -$1.4K | -851 | Closed |
|
|
PSB
155
Piscataqua Savings Bank
Portsmouth,
New Hampshire
| – | -$407 | -250 | Closed |
|
156
Lazard Asset Management
New York
| – | -$270 | -132 | -31% |
|
CRBU Hedge Fund Activity: Q3 2024 in Review
129 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q3 2024, worth a combined $103M — up 18% from $87.6M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of CRBU and 18 opened new positions — a net loss of 10 holders — while 32 trimmed existing stakes and 44 added.
The largest buyer was Schonfeld Strategic Advisors, adding an estimated $1.54M. The largest seller was Renaissance Technologies, cutting an estimated $1.82M.
- 129 institutional investors held Caribou Biosciences (CRBU) as of Q3 2024, down from 140 in Q2 2024.
- Funds reported $103M of Caribou Biosciences stock for Q3 2024, up 18% quarter-over-quarter.
- 18 funds opened new Caribou Biosciences positions in Q3 2024 and 28 closed out, a net change of -10 holders.
- The largest Caribou Biosciences buyer in Q3 2024 was Schonfeld Strategic Advisors, an estimated $1.54M added.
- The largest Caribou Biosciences seller in Q3 2024 was Renaissance Technologies, an estimated $1.82M sold.
Based on aggregated 13F filings for Q3 2024.